Search Results
108 items found for "Cancer"
- 📰 GPCR Weekly News, June 5 to 11, 2023
Autocrine Proteinase-Activated Receptor (PAR) signaling in PC3 prostate cancer cells. GPCRs in Immunology and Oncology The GPCR–Gαs–PKA signaling axis promotes T cell dysfunction and cancer
- 📰 GPCR Weekly News, February 6 to 12, 2023
An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer Structure pulls off rare IPO, raising $161M 3-drug combo leads to 'unprecedented' response in pancreatic cancer
- Mechanistic Understanding of the Palmitoylation of Go Protein in the Allosteric Regulation of...
receptors (aGPCRs)-a major family of GPCRs-play critical roles in the regulation of tissue development and cancer
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
For example, chemotherapy, a powerful standard approach to kill fast-growing cancer cells, has the drawback
- 📰 GPCR Weekly News, March 6 to 12, 2023
GPCRs in Oncology and Immunology GPR176 Promotes Cancer Progression by Interacting with G Protein GNAS to Restrain Cell Mitophagy in Colorectal Cancer.
- 📰 GPCR Weekly News, January 8 to 14, 2024
Caron and her team studied the GPER/GPR30 complex with β1-adrenergic receptor and AKAP5 in MCF7 breast cancer guanylate kinase (MAGUK) scaffold protein, and protein kinase A anchoring protein (AKAP) 5 in MCF7 breast cancer
- Profiling Immune Cell and Platelet Transcriptomes
also opens doors for exploring the roles of these receptors in various pathological states, including cancer
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
scientists uncover “plant-like” behavior in important human cell regulator, opening up a new drug target for cancer spinal cord injury GPCRs in Oncology and Immunology Biochemical pharmacology of adenylyl cyclases in cancer
- 📰 GPCR Weekly News, May 29 to June 4, 2023
GPCRs in Oncology and Immunology A2aR on lung adenocarcinoma cells: A novel target for cancer therapy Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⦿ Oct 28 - Nov 3, 2024
mouse neutrophils Mechanistic exploration of bioactive constituents in Gnetum gnemon for GPCR-related cancer treatment through network pharmacology and molecular docking The Effect of Cancer-Associated Mutations
- GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024
Nominated for Prestigious Prix Galien USA ‘Best Startup’ Award: Pioneering GPCR-Driven Immunotherapies in Cancer future directions Going rogue: mechanisms, regulation, and roles of mutationally activated Gα in human cancer
- Canonical chemokine receptors as scavenging “decoys”
in the chemokine system can also contribute to various diseases, such as inflammatory conditions and cancer
- Odorant G protein-coupled receptors as potential therapeutic targets for adult diffuse gliomas ...
from odor perception, and may contribute to the pathogenesis of disorders including brain diseases and cancers
- Structural dynamics of Smoothened (SMO) in ciliary membrane and its interaction with membrane lipids
signaling pathway, which is involved in embryonic development and is implicated in various types of cancer
- 📰 GPCR Weekly News, July 3 to 9, 2023
Minireview: functional roles of tissue kallikrein, kinins, and kallikrein-related peptidases in lung cancer
- 📰 GPCR Weekly News, June 12 to 18, 2023
GPCRs in Oncology and Immunology The GPCR-Gαs-PKA signaling axis promotes T cell dysfunction and cancer
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
For instance, aberrant endosomal signaling by GPCRs has been linked to disorders such as cancer, neurodegenerative GPCRomics: GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic
- 📰 GPCR Weekly News - January 2 to 8, 2023
GPCRs in Oncology and Immunology Vasoactive intestinal peptide receptor 2 signaling promotes breast cancer
- 📰 GPCR Weekly News
GPCRs in Oncology and Immunology Pan-cancer functional analysis of somatic mutations in G protein-coupled
- 📰 GPCR Weekly News, June 3 to June 9, 2024
correlation study of adhesion G protein-coupled receptors as potential therapeutic targets for breast cancer
- 📰 GPCR Weekly News, May 22 to 28, 2023
intertwining roles of caveolin, oxytocin receptor, and the associated signalling pathways in prostate cancer
- 📰 GPCR Weekly News, October 16 to 22, 2023
reinforces consistent reduction in risk of recurrence across key subgroups of patients with early breast cancer
- Dr. GPCR University registration is now open! Secure your spot now!
GPCRs in Oncology and Immunology Unveiling G-protein coupled receptors as potential targets for ovarian cancer
- 📰 GPCR Weekly News, April 3 to 9, 2023
GPCR Events, Meetings, and Webinars NEW AACR 2023 - American Association for Cancer Research (April 14
- 📰 GPCR Weekly News, March 20 to 26, 2023
kidney disease GPCRs in Oncology and Immunology Purinergic GPCR-integrin interactions drive pancreatic cancer
- 📰 GPCR Weekly News, September 18 to 24, 2023
protein-coupled receptor 37 promotes resistance to cisplatin-induced apoptosis in non-small cell lung cancer
- 📰 GPCR Weekly News, September 4 to 10, 2023
and Immunology [1,2,4]Triazolo[1,5-c]pyrimidines as Tools to Investigate A3 Adenosine Receptors in Cancer
- 📰 GPCR Weekly News, August 28 to September 3, 2023
back again: the lysophosphatidic acid-CCN axis in signal transduction NPFF stimulates human ovarian cancer